UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma

Oncology reports, 2024-12, Vol.52 (6), Article 172

2024

Volltextzugriff (PDF)

Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines

Scientific reports, 2017-06, Vol.7 (1), p.3964-15, Article 3964

2017

Volltextzugriff (PDF)

Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer

Oncology reports, 2020-12, Vol.44 (6), p.2581-2594

2020

Volltextzugriff (PDF)

Detection of high-risk Human Papillomavirus in prostate cancer from a UK based population

Scientific reports, 2023-05, Vol.13 (1), p.7633-7633, Article 7633

2023

Volltextzugriff (PDF)

Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs

International journal of oncology, 2016-11, Vol.49 (5), p.1825-1838

2016

Volltextzugriff (PDF)

Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer

Oncotarget, 2019-03, Vol.10 (18), p.1704-1715

2019

Volltextzugriff (PDF)

Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers

British journal of cancer, 2015-09, Vol.113 (7), p.1010-1019

2015

Volltextzugriff (PDF)

CmeABC Multidrug Efflux Pump Contributes to Antibiotic Resistance and Promotes Campylobacter jejuni Survival and Multiplication in Acanthamoeba polyphaga

Applied and environmental microbiology, 2017-11, Vol.83 (22), p.1

2017

Volltextzugriff (PDF)

Campylobacter-Acanthamoeba interactions

Microbiology (Society for General Microbiology), 2015-05, Vol.161 (Pt 5), p.933-947

2015

Volltextzugriff (PDF)

Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

BMC cancer, 2013-01, Vol.13 (1), p.41-41, Article 41

2013

Volltextzugriff (PDF)

HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer

Cancers, 2021-02, Vol.13 (4), p.638

2021

Volltextzugriff (PDF)

Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition

International journal of oncology, 2016-03, Vol.48 (3), p.908-918

2016

Volltextzugriff (PDF)

Potential probiotic-associated traits revealed from completed high quality genome sequence of Lactobacillus fermentum 3872

Environmental microbiome, 2017-02, Vol.12 (1), Article 19

2017

Volltextzugriff (PDF)

A negative effect of Campylobacter capsule on bacterial interaction with an analogue of a host cell receptor

BMC microbiology, 2014-05, Vol.14 (1), p.141-141, Article 141

2014

Volltextzugriff (PDF)

Co-expression of HER family members in patients with Dukes' C and D colon cancer and their impacts on patient prognosis and survival

PloS one, 2014-03, Vol.9 (3), p.e91139-e91139

2014

Volltextzugriff (PDF)

Growth response of human colorectal tumour cell lines to treatment with afatinib (BIBW2992), an irreversible erbB family blocker, and its association with expression of HER family members

International journal of oncology, 2011-08, Vol.39 (2), p.483-491

2011

Volltextzugriff (PDF)

Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancer

Frontiers in bioscience, 2012-06, Vol.17 (7), p.2698-2724

2012

Volltextzugriff (PDF)

YPTB3816 of Yersinia pseudotuberculosis strain IP32953 is a virulence-related metallo-oligopeptidase

BMC microbiology, 2016-11, Vol.16 (1), p.282-282, Article 282

2016

Volltextzugriff (PDF)

Three-dimensional visualisation of developmental stages of an apicomplexan fish blood parasite in its invertebrate host

Parasites & vectors, 2011-11, Vol.4 (1), p.219-219, Article 219

2011

Volltextzugriff (PDF)

Abstract 2973: Growth response of human liver cancer cell lines to treatment with various agents targeting different members of the HER family and CDKs

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2973-2973

2019

Volltextzugriff (PDF)

Abstract 350: Co-expression and predictive value of HER family members for the response to therapy with cetuximab in patients with metastatic colorectal cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.350-350

2021

Volltextzugriff (PDF)

Crystal and microparticle effects on MDCK cell superoxide production: oxalate-specific mitochondrial membrane potential changes

Free radical biology & medicine, 2005-06, Vol.38 (12), p.1553-1564

2005

Volltextzugriff (PDF)

Prognostic significance and targeting of HER family in colorectal cancer

Frontiers in bioscience, 2013-01, Vol.18 (2), p.394-421

2013

Volltextzugriff (PDF)

A new fish haemogregarine from South Africa and its suspected dual transmission with trypanosomes by a marine leech

Folia parasitologica, 2006-12, Vol.53 (4), p.241-248

2006

Volltextzugriff (PDF)

The Combination of Afatinib With Dasatinib or Miransertib Results in Synergistic Growth Inhibition of Stomach Cancer Cells

World journal of oncology, 2024-04, Vol.15 (2), p.192-208

2024

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(90)
Reviews
(3)

Sprache

Englisch
(93)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma

Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines

Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer

Detection of high-risk Human Papillomavirus in prostate cancer from a UK based population

Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs

Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer

Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers

CmeABC Multidrug Efflux Pump Contributes to Antibiotic Resistance and Promotes Campylobacter jejuni Survival and Multiplication in Acanthamoeba polyphaga

Campylobacter-Acanthamoeba interactions

Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer

Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition

Potential probiotic-associated traits revealed from completed high quality genome sequence of Lactobacillus fermentum 3872

A negative effect of Campylobacter capsule on bacterial interaction with an analogue of a host cell receptor

Co-expression of HER family members in patients with Dukes' C and D colon cancer and their impacts on patient prognosis and survival

Growth response of human colorectal tumour cell lines to treatment with afatinib (BIBW2992), an irreversible erbB family blocker, and its association with expression of HER family members

Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancer

YPTB3816 of Yersinia pseudotuberculosis strain IP32953 is a virulence-related metallo-oligopeptidase

Three-dimensional visualisation of developmental stages of an apicomplexan fish blood parasite in its invertebrate host

Abstract 2973: Growth response of human liver cancer cell lines to treatment with various agents targeting different members of the HER family and CDKs

Abstract 350: Co-expression and predictive value of HER family members for the response to therapy with cetuximab in patients with metastatic colorectal cancer

Crystal and microparticle effects on MDCK cell superoxide production: oxalate-specific mitochondrial membrane potential changes

Prognostic significance and targeting of HER family in colorectal cancer

A new fish haemogregarine from South Africa and its suspected dual transmission with trypanosomes by a marine leech

The Combination of Afatinib With Dasatinib or Miransertib Results in Synergistic Growth Inhibition of Stomach Cancer Cells

Suchergebnisse filtern